Search
for
Sort by
Research 511–540 of 842
- Nivolumab-Induced Alopecia Areata: A Case Report and Literature Review
- Homeostasis and Cancer Symptom in Elemental Concentration Profiles of Hair Observed by Fluorescent X-ray Analysis with Synchrotron Radiation
- Bioguided Fraction and Isolation of the Antitumor Components from<i>Phyllanthus niruri</i>L.
- Acne inversa-like lesions associated with the multi-kinase inhibitor sorafenib
- Sorafenib-induced eruption resembling pityriasis rubra pilaris
- Drug-induced postinfantile giant cell hepatitis
- Case of alopecia induced by sorafenib, possible mechanism similar to alopecia areata
- An in vitro study on the effects of homeopathic Radium bromatum (9CH, 12CH, and 30CH potencies) on cancer cells
- Sorafenib-Associated Facial Acneiform Eruption
- Metformin and Malignant Tumors: Not Over the Hill
- Man made disease: Clinical manifestations of low phenylalanine levels in an inadequately treated phenylketonuria patient and mouse study
- Editorial: Treatment and prognostic assessment of liver cirrhosis and its complications, volume II
- Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment
- Highlights
- Anti-anginal and beta-adrenoceptor blocking drugs
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Feline paraneoplastic alopecia associated with metastasising intestinal carcinoma
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Ritlecitinib: First Approval
- Wnt signaling: the good and the bad
- Metabolic dysfunction in female mice with disruption of 5α-reductase 1
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- Linking diet to acne metabolomics, inflammation, and comedogenesis: an update
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Comorbidities in alopecia areata: A systematic review and meta-analysis
- Hyaluronidase Modulates Inflammatory Response and Accelerates the Cutaneous Wound Healing
- Tinea Capitis: An Overview with Emphasis on Management